VMD VIEMED HEALTHCARE, INC.
Services-Misc Health & Allied Services, NEC · Nasdaq · SEC CIK 1729149 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY21.8%
TTM net income YoY14.8%
TTM EPS YoY11.8%
Revenue 3-yr CAGR22.3%
Net income 3-yr CAGR19.3%
Margins
Gross margin57.4%
Operating margin7.8%
Net margin5.0%
FCF margin6.9%
EBITDA margin12.9%
Returns
ROE11.0%
ROA7.6%
ROIC (approx.)11.8%
Asset turnover1.51x
Leverage & solvency
Liabilities / assets26.8%
Debt / equity0.03x
Current ratio1.25x
Interest coverage—
Cash quality & payout
Operating cash flow / net income3.45x
Accruals ratio-18.7%
Payout ratio—
Capex / revenue10.5%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $80.67M | $78.10M | $75.41M | $76.18M | $71.91M | $63.06M | $59.13M | $60.70M |
| Cost of revenue | $34.48M | $33.05M | $32.59M | $32.08M | $30.57M | $26.32M | $25.85M | $24.56M |
| Gross profit | $46.19M | $45.05M | $42.83M | $44.10M | $41.34M | $36.73M | $33.28M | $36.14M |
| R&D expense | $501,000 | $504,000 | $579,000 | $598,000 | $775,000 | $847,000 | $797,000 | $803,000 |
| SG&A expense | $35.51M | $37.13M | $34.79M | $32.22M | $31.92M | $28.80M | $28.43M | $28.21M |
| Operating income | $6.96M | $4.46M | $4.30M | $8.37M | $5.64M | $5.09M | $3.84M | $6.45M |
| Interest expense | $177,000 | $248,000 | $305,000 | — | $507,000 | $132,000 | $179,000 | — |
| Pretax income | $6.79M | $4.05M | $3.99M | $8.01M | $5.13M | $4.96M | $3.66M | $6.30M |
| Income tax | $2.05M | $1.15M | $1.28M | $2.19M | $1.53M | $1.71M | $952,000 | $1.88M |
| Net income | $4.64M | $2.76M | $2.58M | $5.64M | $3.51M | $3.16M | $2.62M | $4.32M |
| EBITDA | $7.35M | $4.85M | $11.92M | $15.94M | $6.04M | $5.45M | $10.45M | $12.82M |
| EPS (basic) | 0.12 | 0.07 | 0.07 | — | 0.09 | 0.08 | 0.07 | — |
| EPS (diluted) | 0.11 | 0.07 | 0.06 | — | 0.09 | 0.08 | 0.06 | — |
| Weighted avg. shares (diluted) | 41.19M | 41.13M | 40.49M | — | 40.50M | 41.08M | 41.63M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $9.68M | $10.68M | $9.76M | $13.50M | $11.12M | $20.02M | $10.16M | $17.54M |
| Receivables | $34.89M | $32.23M | $31.18M | $25.59M | $27.41M | $26.55M | $26.79M | $24.91M |
| Inventory | $4.55M | $5.27M | $5.18M | $5.05M | $5.27M | $4.32M | $4.51M | $4.32M |
| Current assets | $59.29M | $53.97M | $49.81M | $48.49M | $49.98M | $55.29M | $49.12M | $52.88M |
| PP&E, net | $75.60M | $77.16M | $76.01M | $78.78M | $80.51M | $79.73M | $81.05M | $76.28M |
| Goodwill | $58.94M | $58.94M | $58.94M | $58.94M | $58.46M | $32.99M | $32.99M | $32.99M |
| Intangibles | $1.09M | $1.16M | $1.22M | $1.28M | $1.35M | $783,000 | $816,000 | $848,000 |
| Total assets | $207.63M | $204.22M | $197.36M | $199.15M | $202.36M | $184.60M | $178.08M | $177.07M |
| Current liabilities | $47.32M | $47.89M | $40.71M | $41.06M | $44.19M | $37.27M | $35.49M | $37.33M |
| Short-term debt | $511,000 | $717,000 | $871,000 | $1.09M | $1.55M | $820,000 | $390,000 | $409,000 |
| Long-term debt | $4.51M | $6.37M | $8.33M | $11.29M | $19.59M | $3.46M | $3.53M | $3.59M |
| Total debt | $5.02M | $7.09M | $9.21M | $12.38M | $21.14M | $4.29M | $3.92M | $4.00M |
| Total liabilities | $55.65M | $58.26M | $51.56M | $55.63M | $66.86M | $42.98M | $41.33M | $43.77M |
| Shareholders' equity | $150.09M | $144.03M | $143.86M | $141.54M | $133.61M | $139.73M | $134.76M | $131.39M |
| Net debt | -$4.66M | -$3.59M | -$557,000 | -$1.12M | $10.02M | -$15.73M | -$6.24M | -$13.54M |
| Shares outstanding | 38.05M | 38.09M | 38.53M | 38.02M | 38.02M | 39.61M | 39.52M | 39.13M |
| Cash flow statement | ||||||||
| Operating cash flow | $11.49M | $15.90M | $8.07M | $18.44M | $18.37M | $12.25M | $2.85M | $14.99M |
| Capital expenditure | $8.62M | $8.46M | $6.71M | $8.74M | $7.64M | $8.13M | $15.48M | $11.83M |
| Free cash flow | $2.87M | $7.44M | $1.36M | $9.70M | $10.73M | $4.12M | -$12.63M | $3.16M |
| Investing cash flow | -$7.46M | -$7.84M | -$5.49M | -$7.61M | -$32.30M | -$1.73M | -$8.53M | -$9.20M |
| Financing cash flow | -$5.03M | -$7.15M | -$6.33M | -$8.45M | $5.04M | -$671,000 | -$1.70M | $404,000 |
| Depreciation & amortization | $392,000 | $388,000 | $7.62M | $7.57M | $397,000 | $353,000 | $6.61M | $6.37M |
| Stock-based compensation | $2.48M | $2.03M | $2.45M | $2.30M | $2.18M | $2.34M | $2.31M | $1.52M |
| Share buybacks | $977,000 | $5.32M | $1.44M | $0 | $11.56M | $1.66M | $0 | $0 |
Free plan shows the latest 8 periods; Pro shows all 35 🔒
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-20 06:27.